Literature DB >> 17689681

Sp1 regulates osteopontin expression in SW480 human colon adenocarcinoma cells.

Yoji Takami1, Michael B Russell, Chengjiang Gao, Zhiyong Mi, Hongtao Guo, Christopher R Mantyh, Paul C Kuo.   

Abstract

BACKGROUND: Osteopontin (OPN) mediates cancer metastasis. Mechanisms regulating OPN expression in human colorectal cancer are unknown. Using SW480 colon adenocarcinoma cells, we hypothesized that transcription determines OPN expression.
METHODS: SW480 constitutively express OPN. Transient transfection and deletion analysis of human OPN promoter (full-length 2.1 kb)-luciferase constructs identified cis-regulatory regions. Gelshift and chromatin immunoprecipitation (ChIP) assays identified the trans-regulatory nuclear protein. Using in vitro adhesion, migration, and invasion studies, siRNA was used to determine the functional effect of decreased nuclear protein expression.
RESULTS: A cis-regulatory promoter region, nt-80 to nt-108, upregulated OPN transcription. Gelshift assays demonstrated specific binding of nuclear proteins. Competition with unlabeled mutant oligonucleotides indicated that the region, nt-94 to nt-104 (TGGGCTGGGC), was essential for protein binding in gelshift assays. Confirmatory ChIP assays showed the corresponding nuclear protein to be Sp1. Sp1 expression was ablated with siRNA (si-Sp1), resulting in decreased OPN-dependent adhesion, migration, and invasion by 50%, 70%, and 65%, respectively. Exogenous addition of OPN to si-Sp1 cells restored adhesion, migration, and invasion indices.
CONCLUSIONS: In SW480 human colon cancer cells, we conclude that Sp1 mediated expression of the tumor metastasis protein, OPN, regulates in vitro functional correlates of tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689681      PMCID: PMC2174430          DOI: 10.1016/j.surg.2007.02.015

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  23 in total

Review 1.  Dissecting the metastatic cascade.

Authors:  Klaus Pantel; Ruud H Brakenhoff
Journal:  Nat Rev Cancer       Date:  2004-06       Impact factor: 60.716

2.  Indicators of prognosis after hepatic resection for colorectal secondaries.

Authors:  J Scheele; R Stangl; A Altendorf-Hofmann; F P Gall
Journal:  Surgery       Date:  1991-07       Impact factor: 3.982

3.  The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone.

Authors:  A M Craig; D T Denhardt
Journal:  Gene       Date:  1991-04       Impact factor: 3.688

4.  Characterization of the promoter region of the porcine opn (osteopontin, secreted phosphoprotein 1) gene. Identification of positive and negative regulatory elements and a 'silent' second promoter.

Authors:  Q Zhang; J L Wrana; J Sodek
Journal:  Eur J Biochem       Date:  1992-07-15

5.  Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies.

Authors:  Domenico Coppola; Marianna Szabo; David Boulware; Patrick Muraca; Marwan Alsarraj; Ann F Chambers; Timothy J Yeatman
Journal:  Clin Cancer Res       Date:  2004-01-01       Impact factor: 12.531

6.  Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation.

Authors:  D R Senger; C A Perruzzi; C F Gracey; A Papadopoulos; D G Tenen
Journal:  Cancer Res       Date:  1988-10-15       Impact factor: 12.701

7.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

8.  Cloning and characterization of the human osteopontin gene and its promoter.

Authors:  N Hijiya; M Setoguchi; K Matsuura; Y Higuchi; S Akizuki; S Yamamoto
Journal:  Biochem J       Date:  1994-10-01       Impact factor: 3.857

9.  Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities.

Authors:  J H Smith; D T Denhardt
Journal:  J Cell Biochem       Date:  1987-05       Impact factor: 4.429

Review 10.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

View more
  18 in total

1.  Green tea component epigallocatechin-3-gallate decreases expression of osteopontin via a decrease in mRNA half-life in cell lines of metastatic hepatocellular carcinoma.

Authors:  Matthew A C Zapf; Anai N Kothari; Cynthia E Weber; Matthew L Arffa; Phillip Y Wai; Joseph Driver; Gopal N Gupta; Paul C Kuo; Zhiyong Mi
Journal:  Surgery       Date:  2015-07-17       Impact factor: 3.982

2.  Sp1 transcription factor promotes TMEPAI gene expression and contributes to cell proliferation.

Authors:  Yuyin Li; Ailong Guo; Yajuan Feng; Yueying Zhang; Jianjun Wang; Lifang Jing; Yali Yan; Lei Jing; Zhenxing Liu; Long Ma; Aipo Diao
Journal:  Cell Prolif       Date:  2016-09-14       Impact factor: 6.831

Review 3.  Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers.

Authors:  Dong-Xing Cao; Zhi-Jie Li; Xiao-Ou Jiang; Yick Liang Lum; Ester Khin; Nikki P Lee; Guo-Hao Wu; John M Luk
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

4.  Egr-1 upregulates OPN through direct binding to its promoter and OPN upregulates Egr-1 via the ERK pathway.

Authors:  Qi-Feng Liu; Hong-Wei Yu; Gui-Nan Liu
Journal:  Mol Cell Biochem       Date:  2009-06-26       Impact factor: 3.396

5.  Transcription factor Late SV40 Factor (LSF) functions as an oncogene in hepatocellular carcinoma.

Authors:  Byoung Kwon Yoo; Luni Emdad; Rachel Gredler; Christine Fuller; Catherine I Dumur; Kimberly H Jones; Colleen Jackson-Cook; Zao-Zhong Su; Dong Chen; Utsav H Saxena; Ulla Hansen; Paul B Fisher; Devanand Sarkar
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

6.  Detection of genetic variation and activity analysis of the promoter region of the cattle tRNA-modified gene TRDMT1.

Authors:  Xiaohua Yi; Shuai He; Shuhui Wang; Haidong Zhao; Mingli Wu; Shirong Liu; Xiuzhu Sun
Journal:  Arch Anim Breed       Date:  2021-04-30

7.  Comparative genomic analyses identify common molecular pathways modulated upon exposure to low doses of arsenic and cadmium.

Authors:  Margaret Ann Benton; Julia E Rager; Lisa Smeester; Rebecca C Fry
Journal:  BMC Genomics       Date:  2011-04-01       Impact factor: 3.969

8.  Consistent Differential Expression Pattern (CDEP) on microarray to identify genes related to metastatic behavior.

Authors:  Lam C Tsoi; Tingting Qin; Elizabeth H Slate; W Jim Zheng
Journal:  BMC Bioinformatics       Date:  2011-11-11       Impact factor: 3.169

9.  c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors.

Authors:  Kevin C Flanagan; Elise Alspach; Ermira Pazolli; Shankar Parajuli; Qihao Ren; Laura L Arthur; Roberto Tapia; Sheila A Stewart
Journal:  Oncotarget       Date:  2017-12-05

Review 10.  Abnormal function of telomere protein TRF2 induces cell mutation and the effects of environmental tumor‑promoting factors (Review).

Authors:  Zhengyi Wang; Xiaoying Wu
Journal:  Oncol Rep       Date:  2021-07-19       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.